SVA Life Sciences is pleased to announce that Bindul Turakhia has rejoined the firm as Principal, Life Sciences.
Bindul brings more than 20 years of leadership and advisory experience from top organizations across the pharmaceutical, healthcare, and financial services industries. In his career, he has successfully guided the commercialization of numerous products and indications, while also playing a key role in multiple product acquisitions and divestitures.
Bindul’s deep expertise spans strategic and tactical planning, program execution, and cross-functional team development. These skills position him to deliver significant value to both established and emerging biopharma companies.
Importantly, his long-standing relationships and trusted advisory role within the industry provide an opportunity for clients to transition smoothly as he returns to SVA Life Sciences. The company is committed to ensuring a seamless experience for organizations choosing to continue their collaboration with him.
“Bindul’s return reflects both the strength of our culture and our commitment to strategic growth in the Life Sciences space,” said Bryan Bechtoldt, President and Principal of SVA Consulting. “His proven ability to partner with clients in meaningful ways, combined with his experience leading large-scale commercialization efforts, will allow us to expand our reach while continuing to deliver measurable results.”
Bindul previously served with SVA Life Sciences in a leadership role, and his reappointment highlights SVA Life Sciences’ ability to attract and retain top talent while signaling its continued growth in serving the biopharma market.
“We’ve been fortunate to maintain a strong relationship with Bindul throughout the years, and we’re excited to welcome him back to SVA Life Sciences,” says Andrew Petrasko, Principal at SVA Consulting. “His return not only strengthens our team but also reaffirms our commitment to supporting our clients with experienced leaders they know and trust.”
.jpg)
